| Factor Information | |
|---|---|
| Data ID | 379 |
| Factor | total duration of central venous catheter (CVC) |
| Description | Total number of CVCs and total duration of CVC use prior to thrombosis detection was signi cantly greater in patients in which thromboses were detected than total number of CVCs and duration of CVC use in control patients |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | determine if use of LWMH prophylaxis is associated with a reduction in CVC-related thrombosis risk. |
| p Value | 0.006 |
| Conclusion | The occurrence of thrombosis after pediatric cardiac surgery at our institution was 6.2%, similar to what has been reported in other studies, despite frequent use of low molecular weight heparin. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 444 |
| CHD Type | isolated CHD |
| CHD Subtype | HRHS/HLHS/other |
| Reference | |
|---|---|
| PMID | 30234677 |
| Year | 2018 |
| Title | Analysis of Patient Characteristics and Risk Factors for Thrombosis After Surgery for Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | A retrospective cohort study | |
| Region | Indiana,USA | |
| Method | reviewed | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | cardiothoracic surgery | |
| Group | thrombosis patients(Treatment) | no thrombosis patients(Control) |
| Number | 24 | 64 |
| Age | 0.7 months | 0.7 months |
| Gender (Male: Female) | 17:16 | 32:32 |
| Marker Level | 27(17-62)days(median:25–75th percentile) | 12(5-41)days(median:25–75th percentile) |
